Effect of short-term polyphenol treatment on endothelial dysfunction and thromboxane A2 levels in streptozotocin-induced diabetic mice

Biological and Pharmaceutical Bulletin

Volumn 37, Issue 6, 2014, Pages 1056-1061

  Taguchi, Kumiko ^a   Hida, Mari ^a   Matsumoto, Takayuki ^a   Ikeuchi Takahashi, Yuri ^a   Onishi, Hiraku ^a   Kobayashi, Tsuneo ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Endothelial dysfunction; Nitric oxide; Polyphenol

Indexed keywords

ACETYLCHOLINE; CHLOROGENIC ACID; MORIN; NITRIC OXIDE; RESVERATROL; STREPTOZOCIN; THROMBOXANE A2; THROMBOXANE B2; ANTIOXIDANT; ENDOTHELIUM DERIVED RELAXING FACTOR; FLAVONOID; POLYPHENOL; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; MALE; MOUSE; NONHUMAN; SHORT COURSE THERAPY; SMOOTH MUSCLE RELAXATION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TREATMENT DURATION; VASCULAR RING; ANIMAL; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; MUSCLE ISOMETRIC CONTRACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; THORACIC AORTA; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTIOXIDANTS; AORTA, THORACIC; CHLOROGENIC ACID; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; ENDOTHELIUM-DEPENDENT RELAXING FACTORS; FLAVONOIDS; ISOMETRIC CONTRACTION; MALE; MICE, INBRED ICR; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; OXIDATIVE STRESS; POLYPHENOLS; STILBENES; STREPTOZOCIN; THROMBOXANE A2;

EID: 84901820208     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b14-00157     Document Type: Article

References (38)

1. Hadas K, Randriamboavonjy V, Elgheznawy A, Mann A, Fleming I. Methylglyoxal induces platelet hyperaggregation and reduces thrombus stability by activating PKC and inhibiting P13K/Akt pathway. PLoS ONE, 8, e74401 (2013).
2. Matsumoto T, Watanabe S, Kawamura R, Taguchi K, Kobayashi T. Enhanced uridine adenosine tetraphosphate-induced contraction in renal artery from type 2 diabetic Goto-Kakizaki rats due to activated cyclooxygenase/thromboxane receptor axis. Pflugers Arch., 466, 331-342 (2014).
3. Mellor DD, Madden LA, Smith KA, Kilpatrick ES, Atkin SL. High-polyphenol chocolate reduces endothelial dysfunction and oxidative stress during acute transient hyperglycaemia in type 2 diabetes: a pilot randomized controlled trial. Diabet. Med., 30, 478-483 (2013).
4. Raz I, Wilson PW, Strojek K, Kowalska I, Bozikov V, Gitt AK, Jermendy G, Campaigne BN, Kerr L, Milicevic Z, Jacober SJ. Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the FIEART2D trial. Diabetes Care, 32, 381-386 (2009).
5. de Jager J, Dekker JM, Kooy A, Kostense PJ, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD. Endothelial dysfunction and low-grade inflammation explain much of the excess cardiovascular mortality in individuals with type 2 diabetes: the Hoorn Study. Arterioscler. Thromb. Vasc. Biol., 26, 1086-1093 (2006).
6. Li Volti G, Salomone S, Sorrenti V, Mangiameli A, Urso V, Siarkos I, Galvano F, Salamone F. Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice. Cardiovasc. Diabetol., 10, 62 (2011).
7. Félétou M, Huang Y, Vanhoutte PM. Vsasoconstrictor prostanoids. Pflugers Arch., 459, 941-950 (2010).
8. Ishida K, Matsumoto T, Taguchi K, Kamata K, Kobayashi T. Mechanisms underlying altered extracellular nucleotide-induced contractions in mesenteric arteries from rats in later-stage type 2 diabetes: effect of ANG II type 1 receptor antagonism. Am. J. Physiol. Heart Circ. Physiol., 301, H1850-H1861 (2011).
9. Ishida K, Matsumoto T, Taguchi K, Kamata K, Kobayashi T. Protein kinase C delta contributes to increase in EP3 agonist-induced contraction in mesenteric arteries from type 2 diabetic Goto-Kakizaki rats. Pflugers Arch., 463, 593-602 (2012).
10. Kobayashi T, Nemoto S, Ishida K, Taguchi K, Matsumoto T, Kamata K. Involvement of CaM kinase II in the impairment of endothelial function and eNOS activity in aortas of Type 2 diabetic rats. Clin. Sci., 123, 375-386 (2012).
11. Matsumoto T, Kakami M, Noguchi E, Kobayashi T, Kamata K. Imbalance between endothelium-derived relaxing and contracting factors in mesenteric arteries from aged OLETF rats, a model of Type 2 diabetes. Am. J. Physiol. Heart Circ. Physiol., 293, H1480-H1490 (2007).
12. Matsumoto T, Kobayashi T, Ishida K, Taguchi K, Kamata K. Enhancement of mesenteric artery contraction to 5-HT depends on Rho kinase and Src kinase pathways in the ob/ob mouse model of type 2 diabetes. Br. J. Pharmacol., 160, 1092-1104 (2010).
13. Matsumoto T, Kobayashi T, Wachi H, Seyama Y, Kamata K. Vascular NAD(P)H oxidase mediates endothelial dysfunction in basilar arteries from Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Atherosclerosis, 192, 15-24 (2007).
14. Matsumoto T, Nakayama N, Ishida K, Kobayashi T, Kamata K. Eicosapentaenoic acid improves imbalance between vasodilator and vasoconstrictor actions of endothelium-derived factors in mesenteric arteries from rats at chronic stage of type 2 diabetes. J. Pharmacol. Exp. Ther., 329, 324-334 (2009).
15. Taguchi K, Morishige A, Matsumoto T, Kamata K, Kobayashi T. Enhanced estradiol-induced vasorelaxation in aortas from type 2 diabetic mice may reflect a compensatory role of p38 MAPK-mediated eNOS activation. Pflugers Arch., 464, 205-215 (2012).
16. Taguchi K, Matsumoto T, Kamata K, Kobayashi T. G protein-coupled receptor kinase 2, with β-arrestin 2, impairs insulin-induced Akt/endothelial nitric oxide synthase signaling in ob/ob mouse aorta. Diabetes, 61, 1978-1985 (2012).
17. Manach C, Mazur A, Scalbert A. Polyphenols and prevention of cardiovascular diseases. Curr. Opin. Lipidol., 16, 77-84 (2005).
18. Matsumoto T, Watanabe S, Kawamura R, Taguchi K, Kobayashi T. Epigallocatechin gallate attenuates ET-1-induced contraction in carotid artery from type 2 diabetic OLETF rat at chronic stage of disease. Life Sci., S0024-3205(13)00738-8 (2013).
19. Kim JA, Formoso G, Li Y, Potenza MA, Marasciulo FL, Montagnani M, Quon MJ. Epigallocatechin gallate, a green tea polyphenol, mediates NO-dependent vasodilation using signaling pathways in vascular endothelium requiring reactive oxygen species and Fyn. J. Biol. Chem., 282, 13736-13745 (2007).
20. Du WY, Chang C, Zhang Y, Liu YY, Sun K, Wang CS, Wang MX, Liu Y, Wang F, Fan JY, Li PT, Han JY. High-dose chlorogenic acid induces inflammation reactions and oxidative stress injury in rats without implication of mast cell degranulation. J. Ethnopharmacol., 147, 74-83 (2013).
21. Groebler LK, Wang XS, Kim HB, Shanu A, Hossain F, McMahon AC, Witting PK. Cosupplementation with a synthetic, lipid-soluble polyphenol and vitamin C inhibits oxidative damage and improves vascular function yet does not inhibit acute renal injury in an animal model of rhabdomyolysis. Free Radic. Biol. Med., 52, 1918-1928 (2012).
22. Reaven GM, Twersky J, Chang H. Abnormalities of carbohydrate and lipid metabolism in Dahl rats. Hypertension, 18, 630-635 (1991).
23. Herrera MD, Zarzuelo A, Jiménez J, Marhuenda E, Duarte J. Effects of flavonoids on rat aortic smooth muscle contractility: structure-activity relationships. Gen. Pharmacol., 27, 273-277 (1996).
24. Kang DG, Moon MK, Sohn EJ, Lee DH, Lee HS. Effects of morin on blood pressure and metabolic changes in fructose-induced hypertensive rats. Biol. Pharm. Bull., 27, 1779-1783 (2004).
25. Hwang SJ, Kim YW, Park Y, Lee HJ, Kim KW. Anti-inflammatory effects of chlorogenic acid in lipopolysaccharide-stimulated RAW 264.7 cells. Inflamm. Res., 63, 8190 (2014).
26. Vanaja K, Wahl MA, Bukarica L, Heinle H. Liposomes as carriers of the lipid soluble antioxidant resveratrol: Evaluation of amelioration of oxidative stress by additional antioxidant vitamin. Life Sci., 93, 917-923 (2013).
27. Takenouchi Y, Kobayashi T, Taguchi K, Matsumoto T, Kamata K. Gender differences in vascular reactivity of aortas from streptozotocin-induced diabetic mice. Biol. Pharm. Bull., 33, 1692-1697 (2010).
28. Matsumoto T, Kakami M, Kobayashi T, Kamata K. Gender differences in vascular reactivity to endothelin-1 (1-31) in mesenteric arteries from diabetic mice. Peptides, 29, 1338-1346 (2008).
29. Shin JY, Sohn J, Park KH. Chlorogenic acid decreases retinal vascular hyperpermeability in diabetic rat model. J. Korean Med. Sci., 28, 608-613 (2013).
30. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov., 5, 493-506 (2006).
31. Tucsek Z, Radnai B, Racz B, Debreceni B, Priber JK, Dolowschiak T, Palkovics T, Galiyas F Jr, Sumegi B, Veres B. Suppressing LPS-induced early signal transduction in macrophages by a polyphenol degradation product: a critical role of MKP-1. J. Leukoc. Biol., 89, 105-111 (2011).
32. Naderali EK, Doyle PJ, Williams G. Resveratrol induces vasorelaxation of mesenteric and uterine arteries from female guinea-pigs. Clin. Sci. (Lond.), 98, 537-543 (2000).
33. Orallo F, Alvarez E, Camiña M, Leiro JM, Gomez E, Fernández P. The possible implication of trans-resveratrol in the cardioprotective effects of long-term moderate wine consumption. Mol. Pharmacol., 61, 294-302 (2002).
34. Rush JW, Quadrilatero J, Levy AS, Ford RJ. Chronic resveratrol enhances endothelium-dependent relaxation but does not alter eNOS levels in aorta of spontaneously hypertensive rats. Exp. Biol. Med. (Maywood), 232, 814-822 (2007).
35. Aubin MC, Lajoie C, Clement R, Gosselin H, Calderone A, Perrault LP. Female rats fed a high-fat diet were associated with vascular dysfunction and cardiac fibrosis in the absence of overt obesity and hyperlipidemia: therapeutic potential of resveratrol. J. Pharmacol. Exp. Ther., 325, 961-968 (2008).
36. Zhang H, Zhang J, Ungvari Z, Zhang C. Resveratrol improves endothelial function: role of TNFα and vascular oxidative stress. Arterioscler. Thromb. Vasc. Biol., 29, 1164-1171 (2009).
37. Nuno DW, Harrod JS, Lamping KG. Sex-dependent differences in Rho activation contribute to contractile dysfunction in type 2 diabetic mice. Am. J. Physiol. Heart Circ. Physiol., 297, H1469-H1477 (2009).
38. Duthie G, Morrice P. Antioxidant capacity of flavonoids in hepatic microsomes is not reflected by antioxidant effects in vivo. Oxid. Med. Cell. Longev., 2012, 165127 (2012).